Nursing care
Type 1 Diabetes nursing care: what to assess and what to do first
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Type 1 diabetes nursing care centres on the fact that the pancreas produces no insulin at all, so insulin must never be omitted, even when the patient is vomiting or unable to eat. Assessment focuses on blood glucose trends and signs of DKA, and the core teaching point is the sick-day rule: continue insulin, adjust the dose, and monitor ketones.
The clinical picture
Type 1 diabetes results from autoimmune destruction of the pancreatic beta cells, leaving the patient with no endogenous insulin production. This is an absolute deficiency, not a relative one, and it is the single fact that shapes every nursing decision that follows. Onset is often abrupt, frequently in childhood or young adulthood, and can present as diabetic ketoacidosis in a previously undiagnosed patient.
Classic presentation includes polyuria, polydipsia, polyphagia, and unexplained weight loss despite normal or increased appetite. Because there is no baseline insulin, these patients are prone to rapid metabolic decompensation when insulin delivery is interrupted, whether from a missed dose, pump failure, or illness. Fatigue, blurred vision, and slow wound healing may also be present at diagnosis or during periods of poor control.
Assessment: what to look for and in what order
Start with blood glucose, checked on admission and at regular intervals thereafter, since both hyperglycaemia and hypoglycaemia are acute risks in this population. Assess for signs of DKA: Kussmaul respirations, fruity breath odour, abdominal pain, nausea, and altered mental status, alongside serum ketones and blood pH if DKA is suspected. A type 1 patient with vomiting and high glucose is assumed to be developing DKA until proven otherwise.
Review the insulin regimen in use, basal-bolus injections, an insulin pump, and confirm the timing of the last dose. Ask specifically whether any dose has been skipped or delayed, since even a single missed basal dose can precipitate ketosis within hours given the total absence of endogenous insulin. Check injection or infusion sites for lipodystrophy or infection, and assess the patient's understanding of carbohydrate counting and correction dosing, since knowledge gaps are common at diagnosis and after regimen changes.
Immediate interventions
For suspected or confirmed DKA, prioritise IV fluid resuscitation with isotonic saline, followed by an IV insulin infusion once potassium levels are known to be adequate, since insulin drives potassium into cells and can precipitate dangerous hypokalaemia. Monitor blood glucose hourly during insulin infusion and add dextrose to IV fluids once glucose approaches 200 to 250 mg/dL to prevent overcorrection.
For hypoglycaemia, give 15 to 20 grams of fast-acting carbohydrate if the patient is conscious and able to swallow, or IV dextrose or IM glucagon if not, then recheck glucose in 15 minutes and repeat as needed. Never withhold a scheduled basal insulin dose in a type 1 patient simply because oral intake is reduced; instead, adjust the bolus or correction dose and continue basal coverage, since stopping basal insulin entirely risks rapid ketosis.
Ongoing nursing management
Coordinate a consistent schedule of blood glucose monitoring aligned with meals and insulin timing, and trend results rather than reacting to isolated values. Support transition from IV to subcutaneous insulin after DKA resolution by overlapping the two, giving the first subcutaneous dose 1 to 2 hours before stopping the infusion, since insulin has a short half-life and a gap leaves the patient unprotected.
Monitor for signs of chronic complications relevant to long-standing type 1 disease, including retinopathy, nephropathy, and peripheral neuropathy, and reinforce the role of tight glycaemic control in reducing these risks. Assess psychosocial adjustment, particularly in adolescents managing a lifelong condition, since diabetes distress and insulin omission for weight control are recognised risks in this group.
Patient and family education
The sick-day rule is the teaching point that prevents the most admissions: insulin is continued even when the patient is not eating, because the deficiency is absolute and food intake does not change the need for basal coverage. Teach patients to increase monitoring frequency during illness, check ketones when glucose exceeds 240 mg/dL, and contact their provider if ketones are moderate to large or if vomiting prevents fluid intake.
Cover injection or pump site rotation, recognition of hypoglycaemia symptoms and treatment, and the importance of never stopping insulin without medical guidance. Teach carbohydrate counting for those on flexible dosing, and confirm the family knows how to administer glucagon for severe hypoglycaemia. Reinforce that alcohol, exercise, and stress all affect glucose unpredictably and require closer monitoring, not a change in the basic sick-day principle.
How this appears on the NCLEX
NCLEX questions frequently test the sick-day rule directly: a scenario describes a type 1 patient who is vomiting and asks whether to hold insulin, and the correct answer is to continue insulin, adjust as needed, and monitor ketones, not to withhold the dose. Questions distinguish type 1 from type 2 by testing for recognition that type 1 patients can develop DKA rapidly while type 2 patients more commonly progress toward HHS.
Expect priority-setting items involving insulin administration technique, timing of subcutaneous insulin relative to IV infusion discontinuation, and recognition of hypoglycaemia versus hyperglycaemia symptoms. Questions on pump therapy may test troubleshooting, since a disconnected or malfunctioning pump in a type 1 patient can lead to ketosis within hours due to the complete absence of a basal insulin reserve.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our endocrine practice questions are the closest set to what this page covers.
Common questions
Should insulin be held if a type 1 diabetic patient is not eating?
No. Basal insulin should be continued regardless of oral intake, because the patient produces no insulin of their own. The bolus or correction dose may be adjusted based on glucose and intake, but stopping insulin entirely risks rapid ketosis.
What is the priority assessment for a type 1 diabetic with vomiting and high glucose?
Assess for diabetic ketoacidosis: check serum or urine ketones, respiratory pattern, and mental status. This combination is treated as DKA until ruled out, given how quickly it can develop with absolute insulin deficiency.
Why can potassium drop during insulin treatment for DKA?
Insulin drives potassium into cells along with glucose, which can cause a dangerous drop in serum potassium even though total body potassium may be normal or low. Potassium levels must be checked before starting an insulin infusion and monitored closely throughout treatment.
How is IV insulin transitioned to subcutaneous insulin after DKA?
The first subcutaneous dose is given 1 to 2 hours before stopping the IV infusion, because subcutaneous insulin takes time to reach effective levels. Stopping the infusion without this overlap leaves the patient without insulin coverage during the gap.
What distinguishes type 1 diabetes from type 2 on the NCLEX?
Type 1 involves an absolute lack of insulin and a higher risk of rapid DKA, while type 2 involves insulin resistance and more commonly progresses toward hyperosmolar hyperglycaemic state. Questions often use the sick-day insulin rule to test recognition of type 1's absolute deficiency.